Hemangioendotelioma hepático difuso de evolución fatal: antes y después del propranolol / Diffuse hepatic hemangiomatosis fatal outcome: before and after propranolol
Acta pediatr. esp
; 71(11): e376-e380, dic. 2013. ilus
Article
in Spanish
| IBECS
| ID: ibc-118835
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
El hemangioendotelioma hepático difuso neonatal es una entidad que, en los casos sintomáticos progresivos, puede tener un pronóstico infausto pese al tratamiento clásico. Desde hace 2 años se viene utilizando el propranolol con resultados óptimos, aunque no existen comunicaciones en este sentido a nivel nacional (AU)
ABSTRACT
The diffuse neonatal hemangiomatosis is an entity that, in the symptomatic and progressive cases, can have a bad prognostic despite receiving the classic treatment. Since two years ago, propanolol is used with successful results, but there are not many articles in that sense at national level (AU)
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Propranolol
/
Heart Failure
/
Hemangioendothelioma
Type of study:
Etiology study
/
Prognostic study
/
Risk factors
Limits:
Female
/
Humans
/
Male
/
Infant, Newborn
Language:
Spanish
Journal:
Acta pediatr. esp
Year:
2013
Document type:
Article
Institution/Affiliation country:
Hospital General Universitario de Elche/España
